CHAPTER 1. Industry Overview of Spatial Genomics & Transcriptomics Market
1.1. Definition and Scope
1.1.1. Definition of Spatial Genomics & Transcriptomics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Spatial Genomics & Transcriptomics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Spatial Genomics & Transcriptomics Market By Product
1.2.3. Spatial Genomics & Transcriptomics Market By Technology
1.2.4. Spatial Genomics & Transcriptomics Market By End-Use
1.2.5. Spatial Genomics & Transcriptomics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data End-Use
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Spatial Genomics & Transcriptomics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Spatial Genomics & Transcriptomics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Spatial Genomics & Transcriptomics Market By Product
4.1. Introduction
4.2. Spatial Genomics & Transcriptomics Revenue By Product
4.2.1. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast, By Product, 2018-2030
4.2.2. Instruments
4.2.2.1. Instruments Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.2. By Type
4.2.2.2.1. By Type Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.2.2. IHC
4.2.2.2.2.1. IHC Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.2.3. Sequencing Platforms
4.2.2.2.3.1. Sequencing Platforms Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.2.4. Mass Spectrometry
4.2.2.2.4.1. Mass Spectrometry Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.2.5. Microscopy
4.2.2.2.5.1. Microscopy Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.2.6. Flow Cytometry
4.2.2.2.6.1. Flow Cytometry Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.2.7. Others
4.2.2.2.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3. By Mode
4.2.2.3.1. By Mode Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.2. Manual
4.2.2.3.2.1. Manual Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.3. Semi-automated
4.2.2.3.3.1. Semi-automated Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.4. Automated
4.2.2.3.4.1. Automated Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3. Software
4.2.3.1. Software Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.2. Imaging Tools
4.2.3.2.1. Imaging Tools Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.3. Bioinformatics Tools
4.2.3.3.1. Bioinformatics Tools Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.4. Storage and Management Databases
4.2.3.4.1. Storage and Management Databases Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.4. Consumables
4.2.4.1. Consumables Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 5. Spatial Genomics & Transcriptomics Market By Technology
5.1. Introduction
5.2. Spatial Genomics & Transcriptomics Revenue By Technology
5.2.1. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast, By Technology, 2018-2030
5.2.2. Spatial Transcriptomics
5.2.2.1. Spatial Transcriptomics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.2. Sequencing-Based Methods
5.2.2.2.1. Sequencing-Based Methods Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.2.2. In Situ Sequencing
5.2.2.2.2.1. In Situ Sequencing Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.2.3. Laser Capture Microdissection (LCM)
5.2.2.2.3.1. Laser Capture Microdissection (LCM) Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.2.4. Microtomy Sequencing
5.2.2.2.4.1. Microtomy Sequencing Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.2.5. Transcriptome In-Vivo Analysis (TIVA)
5.2.2.2.5.1. Transcriptome In-Vivo Analysis (TIVA) Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.3. Microscopy-based RNA Imaging Techniques
5.2.2.3.1. Microscopy-based RNA Imaging Techniques Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.3.2. Padlock Probes/ Rolling Circle Amplification
5.2.2.3.2.1. Padlock Probes/ Rolling Circle Amplification Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.3.3. Single Molecule RNA Fluorescence In-Situ Hybridization
5.2.2.3.3.1. Single Molecule RNA Fluorescence In-Situ Hybridization Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.3.4. Branched DNA Probes
5.2.2.3.4.1. Branched DNA Probes Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.2.4. IHC
5.2.2.4.1. IHC Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Spatial Genomics
5.2.3.1. Spatial Genomics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3.2. Microscopy-based Live DNA Imaging
5.2.3.2.1. Microscopy-based Live DNA Imaging Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3.3. FISH
5.2.3.3.1. FISH Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3.4. Massively-Parallel Sequencing
5.2.3.4.1. Massively-Parallel Sequencing Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3.5. Genome Perturbation Tools
5.2.3.5.1. Genome Perturbation Tools Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3.6. Biochemical Techniques
5.2.3.6.1. Biochemical Techniques Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3.7. Others
5.2.3.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. Spatial Genomics & Transcriptomics Market By End-Use
6.1. Introduction
6.2. Spatial Genomics & Transcriptomics Revenue By End-Use
6.2.1. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast, By End-Use, 2018-2030
6.2.2. Pharmaceutical Manufacturer
6.2.2.1. Pharmaceutical Manufacturer Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.3. Academic Customers
6.2.3.1. Academic Customers Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.4. Translational Research
6.2.4.1. Translational Research Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.5. Diagnostic Customers
6.2.5.1. Diagnostic Customers Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Spatial Genomics & Transcriptomics Market By Country
7.1. North America Spatial Genomics & Transcriptomics Market Overview
7.2. U.S.
7.2.1. U.S. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
7.2.2. U.S. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
7.2.3. U.S. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
7.3. Canada
7.3.1. Canada Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
7.3.2. Canada Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
7.3.3. Canada Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Spatial Genomics & Transcriptomics Market By Country
8.1. Europe Spatial Genomics & Transcriptomics Market Overview
8.2. U.K.
8.2.1. U.K. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
8.2.2. U.K. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
8.2.3. U.K. Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.3. Germany
8.3.1. Germany Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
8.3.2. Germany Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
8.3.3. Germany Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.4. France
8.4.1. France Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
8.4.2. France Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
8.4.3. France Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.5. Spain
8.5.1. Spain Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
8.5.2. Spain Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
8.5.3. Spain Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
8.6.2. Rest of Europe Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
8.6.3. Rest of Europe Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Spatial Genomics & Transcriptomics Market By Country
9.1. Asia Pacific Spatial Genomics & Transcriptomics Market Overview
9.2. China
9.2.1. China Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
9.2.2. China Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
9.2.3. China Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.3. Japan
9.3.1. Japan Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
9.3.2. Japan Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
9.3.3. Japan Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.4. India
9.4.1. India Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
9.4.2. India Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
9.4.3. India Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.5. Australia
9.5.1. Australia Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
9.5.2. Australia Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
9.5.3. Australia Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.6. South Korea
9.6.1. South Korea Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
9.6.2. South Korea Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
9.6.3. South Korea Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
9.7.2. Rest of Asia-Pacific Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
9.7.3. Rest of Asia-Pacific Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Spatial Genomics & Transcriptomics Market By Country
10.1. Latin America Spatial Genomics & Transcriptomics Market Overview
10.2. Brazil
10.2.1. Brazil Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
10.2.2. Brazil Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
10.2.3. Brazil Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.3. Mexico
10.3.1. Mexico Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
10.3.2. Mexico Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
10.3.3. Mexico Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
10.4.2. Rest of Latin America Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
10.4.3. Rest of Latin America Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Spatial Genomics & Transcriptomics Market By Country
11.1. Middle East & Africa Spatial Genomics & Transcriptomics Market Overview
11.2. GCC
11.2.1. GCC Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
11.2.2. GCC Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
11.2.3. GCC Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
11.3. South Africa
11.3.1. South Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
11.3.2. South Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
11.3.3. South Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Product, 2018-2030
11.4.2. Rest of Middle East & Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By Technology, 2018-2030
11.4.3. Rest of Middle East & Africa Spatial Genomics & Transcriptomics Revenue (USD Million) and Forecast By End-Use, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Spatial Genomics & Transcriptomics Market
12.1. Spatial Genomics & Transcriptomics Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Spatial Genomics & Transcriptomics Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. NanoString Technologies
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2021
13.1.3.2. NanoString Technologies 2021 Spatial Genomics & Transcriptomics Business Regional Distribution
13.1.4. Product/Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. 10x Genomics
13.3. CARTANA AB
13.4. Horizon Discovery Group plc
13.5. Illumina, Inc.
13.6. S2 Genomics, Inc.
13.7. Dovetail Genomics
13.8. Seven Bridges Genomic
13.9. Advanced Cell Diagnostics.
The estimated value of global spatial genomics & transcriptomics market in 2021 was accounted to be USD 184 Million.
The projected CAGR spatial genomics & transcriptomics market during the analysis period of 2022 to 2030 is 8.9%.
The prominent players of the global spatial genomics & transcriptomics market are NanoString Technologies, 10x Genomics, CARTANA AB, Horizon Discovery Group plc, Illumina, Inc., S2 Genomics, Inc., Dovetail Genomics, Seven Bridges Genomic, and Advanced Cell Diagnostics.
North America held the dominating spatial genomics & transcriptomics during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for spatial genomics & transcriptomics during the analysis period of 2022 to 2030.
Increasing adoption in drug discovery & development, and emergence of novel products, drives the growth of global spatial genomics & transcriptomics market.
Based on end-use, academic customers segment is expected to hold the maximum share spatial genomics & transcriptomics market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date